Not applicableUnknownNCT04134169What this trial is testingLong-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)Who this might be right forRheumatoid Arthritis Kang Stem Biotech Co., Ltd. 28
Large-scale testing (Phase 3)Study completedNCT01377012What this trial is testingEfficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα AgentsWho this might be right forRheumatoid Arthritis Novartis Pharmaceuticals 637
Testing effectiveness (Phase 2)Study completedNCT00810836What this trial is testingEfficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Biogen 153
Large-scale testing (Phase 3)Ended earlyNCT01292265What this trial is testingA 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis UCB Pharma 3
Large-scale testing (Phase 3)Study completedNCT01856309What this trial is testingLong-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003Who this might be right forArthritis, Rheumatoid Janssen Research & Development, LLC 1,820
Testing effectiveness (Phase 2)Ended earlyNCT02270632What this trial is testingA Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTXWho this might be right forRheumatoid Arthritis Philogen S.p.A. 27
Not applicableStudy completedNCT00116714What this trial is testingRheumatoid Arthritis (DMARD) Intervention and UtilizationStudyWho this might be right forRheumatoid Arthritis Amgen 4,968
Testing effectiveness (Phase 2)Ended earlyNCT00805467What this trial is testingOpen-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 StudiesWho this might be right forRheumatoid Arthritis AstraZeneca 624
Not applicableStudy completedNCT01656278What this trial is testingAn MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid ArthritisWho this might be right forArthritisArthritis, RheumatoidJoint Diseases+4 more Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen 200
Early research (Phase 1)Study completedNCT01336218What this trial is testingEffects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.Who this might be right forRheumatoid ArthritisHealthy Volunteers AstraZeneca 15
Not applicableStudy completedNCT01078116What this trial is testingCost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Abbott 124
Testing effectiveness (Phase 2)Looking for participantsNCT06599658What this trial is testingCOVID-19 Booster and IIV Schedule in Immunocompromised HostsWho this might be right forCOVID 19InfluenzaRheumatoid Arthritis (RA)+5 more McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Early research (Phase 1)Looking for participantsNCT06994143What this trial is testingCLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis (RA Cullinan Therapeutics Inc. 37
Not applicableLooking for participantsNCT06889415What this trial is testingRheumatoid Arthritis and Osteosarcopenia: Associated FactorsWho this might be right forOsteosarcopeniaRheumatoid Arthritis (RA)Sarcopenia Konya Beyhekim Training and Research Hospital 200
Early research (Phase 1)Study completedNCT06055023What this trial is testingPhase I Clinical Study of ZL-82 TabletsWho this might be right forRheumatoid Arthritis (RA)Inflammatory Bowel Disease - IBD1 Chengdu Zenitar Biomedical Technology Co., Ltd 69
Post-approval studies (Phase 4)WithdrawnNCT01067430What this trial is testingComparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Northumbria Healthcare NHS Foundation Trust
Not applicableEnded earlyNCT01083563What this trial is testingDraining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion TherapyWho this might be right forRheumatoid Arthritis University of Rochester 7
Testing effectiveness (Phase 2)WithdrawnNCT01204138What this trial is testingConcomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARAWho this might be right forArthritis, Rheumatoid Stanford University
Large-scale testing (Phase 3)Study completedNCT00535782What this trial is testingThe Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 132
Post-approval studies (Phase 4)UnknownNCT03895879What this trial is testingUse of Tocilizumab Drug Levels to Optimize Treatment in RAWho this might be right forRheumatoid Arthritis Reade Rheumatology Research Institute 98